• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AHI
Click for more information
0.00% 9.2¢

ADVANCED HEALTH INTELLIGENCE LTD - Charts / Financials

Market Cap $22.60M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Advanced Health Intelligence Limited is an Australia-based company that provides... Advanced Health Intelligence Limited is an Australia-based company that provides biometric-derived digital healthcare solutions. The Company’s products include Biometric Health Assessment (BHA), FaceScan, and BodyScan. Its BHA delivers preventative healthcare measures and refines risk stratification across populations. Its comprehensive insights cover a range of health vitals and risk predictions, allowing its partners to guide individuals into personalized stepped-care pathways. This includes connecting high-risk individuals to traditional primary care, telehealth, or e-health programs. FaceScan estimates vital signs and predicts the risk of chronic disease on a smartphone or Web browser. FaceScan provides estimated readings on heart rate, respiration rate, blood pressure and more in 30 seconds or less. BodyScan is optimized to run on-device using only a smartphone, to deliver accurate body dimension and composition estimates in 60 seconds or less.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 06.35am 19/04/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Mr. Scott Montgomery Chief Executive Officer, Managing Director, Executive Director
Mr. Simon Durack Chief Financial Officer, Company Secretary
Mr. Olly Bridge Chief Operations Officer
Mr. Terence Stupple Chief Technology Officer
Mr. Riaan Conradie Chief Science Officer
Dr. Katherine Iscoe Executive Director
Mr. Kevin Baum Chief Product Officer
Mr. Vlado Bosanac Head of Strategy and Revenue Growth
Dr. Manie De Klerk Clinical Director
Mr. Dylan Garnett Chief Innovation Officer
Mr. Nicholas Prosser Interim Non-Executive Chairman of the Board
Mr. Peter J. Goldstein Non-Executive Director
Mr. Dato Low Koon Poh Non-Executive Director
Mr. Michael Melby Non-Executive Director
Ms. Jacqueline Yee Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
9.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $22.60M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Top Stories

Market Update: Energy keeps light bright in a sea of red

The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Crypto world awaits overnight Bitcoin halving event The four-yearly Bitcoin halving is set to happen in the early hours of tomorrow morning (Saturday, April 20) - it's an event that industry leader Swyftx likened to 'the Olympic Games for the crypto industry'.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.